comparemela.com

Latest Breaking News On - Century therapeutics company profile - Page 1 : comparemela.com

Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Update

Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Update
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Adrienne-farid
Piper-sandler
Century-therapeutics-company-profile
Nasdaq
Mabel-hall
Jacobs-levy-equity-management-inc
Canaccord-genuity-group
Century-therapeutics-inc
Mirae-asset-global-investments-co
Hermes-inc
Century-therapeutics
Get-free-report

Q1 2025 Earnings Estimate for Century Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:IPSC)

Q1 2025 Earnings Estimate for Century Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:IPSC)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Adrienne-farid
Hermes-inc
Mirae-asset-global-investments-co
Century-therapeutics-company-profile
Securities-exchange-commission
Century-therapeutics-inc
Vanguard-group-inc
Canaccord-genuity-group
Nasdaq
Mabel-hall
Century-therapeutics

Century Therapeutics, Inc. (NASDAQ:IPSC) Insider Sells $15,600.00 in Stock

Century Therapeutics, Inc. (NASDAQ:IPSC) Insider Sells $15,600.00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler
Gregory-russotti
Mirae-asset-global-investments-co
Hermes-inc
Nasdaq
Mabel-hall
Century-therapeutics-company-profile
Canaccord-genuity-group
Century-therapeutics-inc
Securities-exchange-commission
Century-therapeutics
Get-free-report

Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 […]

Adrienne-farid
Century-therapeutics-inc
Nasdaq
Mabel-hall
Virtu-financial
Vanguard-group-inc
Century-therapeutics-company-profile
Barclays-plc
Canaccord-genuity-group
Securities-exchange-commission
Century-therapeutics
Get-free-report

Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Recommendation of "Moderate Buy" from Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among […]

Adrienne-farid
Century-therapeutics-company-profile
Canaccord-genuity-group
Blackrock-inc
Hermes-inc
Century-therapeutics-inc
Securities-exchange-commission
Nasdaq
Vanguard-group-inc
Century-therapeutics
Get-free-report
Marketbeat-ratings

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.